Seraphim rolls out Innovative Blade Bifacial Solar Module

0
219

BEIJINGMay 15, 2019 – Seraphim has recently rolled out an innovative solar module, Blade Bifacial module. According to Seraphim, the new product integrates industry-leading half-cell technology and latest bifacial PERC cell technology, allowing it to have such features as low internal power loss, reduced hot spot potential, higher power output and improved reliability.

Compared to traditional modules, half-cell modules have lower current and series resistance, which can minimize mismatch losses, internal power losses, and shadow effects. Besides, the application of the bifacial PERC cell technology in the new product can also increase the power generation by 10 to 30 percent, making the new product more cost-effective.

Apart from the higher performance, the Seraphim Blade Bifacial module is much lighter as it uses the 2.0 mm double AR coating tempered glass, instead of the 2.5 mm glass used by most PV manufacturers, making it easy for installation and saving transportation costs.

“The technical upgrade of the PV module, as a core component of the power station system, is an important measure to reduce the electricity cost and promote on-grid PV power at a fair price. The integration of the half-cell technology and the bifacial PERC cell technology is an important route to develop the PV module technology and adapt to the needs of the terminal market. In view of its excellent stability, we have extended the product warranty of the monocrystal PERC half-cell modules to 15 years, 50 percent more than the 10-year warranty on the market,” said President of Seraphim.

He also added that Seraphim has set up a new plant in north China’s Shanxi Provincejointly with Shanxi Lu’An Photovoltaics Technology Co. Ltd. to manufacture one gigawatt of ultra-efficient modules including the bifacial half-cell modules annually. At present, the new plant has entered the trial operation stage and the first batch of the modules has rolled off the assembly line for shipment.

LEAVE A REPLY

Please enter your comment!
Please enter your name here